PHCC.F Stock Overview
Through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
PHC Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥7.67 |
| 52 Week High | JP¥8.10 |
| 52 Week Low | JP¥7.17 |
| Beta | 0.80 |
| 11 Month Change | 5.21% |
| 3 Month Change | 5.50% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -26.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHCC.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -0.8% | 0.7% |
| 1Y | n/a | 21.2% | 32.3% |
Return vs Industry: Insufficient data to determine how PHCC.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how PHCC.F performed against the US Market.
Price Volatility
| PHCC.F volatility | |
|---|---|
| PHCC.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: PHCC.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHCC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 9,245 | Kay Deguchi | phchd.com |
PHC Holdings Corporation, through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan. It operates through Diabetes Management, Healthcare Solutions, and Diagnostic & Life Sciences segments. The company offers blood glucose monitoring systems, continuous glucose monitoring systems, and diabetes application; patient and record billing software, including electronic medical record system, electronic medication history system, and healthcare note service; and diagnostic testing products, which include clinical testing, diagnostic reagents and instruments, and drug development support products.
PHC Holdings Corporation Fundamentals Summary
| PHCC.F fundamental statistics | |
|---|---|
| Market cap | US$962.27m |
| Earnings (TTM) | -US$90.48m |
| Revenue (TTM) | US$2.52b |
0.4x
P/S Ratio-10.6x
P/E RatioIs PHCC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHCC.F income statement (TTM) | |
|---|---|
| Revenue | JP¥357.76b |
| Cost of Revenue | JP¥199.02b |
| Gross Profit | JP¥158.74b |
| Other Expenses | JP¥171.61b |
| Earnings | -JP¥12.87b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 13, 2024
| Earnings per share (EPS) | -102.02 |
| Gross Margin | 44.37% |
| Net Profit Margin | -3.60% |
| Debt/Equity Ratio | 189.5% |
How did PHCC.F perform over the long term?
See historical performance and comparison